The ChEMBL database contains over 2.4 million compound bioactivity measurements from screening over 622,824 compounds, including 24,000 natural products. This data is extracted from curating 34,000 publications. The database can be filtered and analyzed to aid in drug discovery by developing screening libraries for identifying lead compounds. Albiglutide is a drug composed of a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin. Standard conventions are used in representing stereochemistry in the structures stored in the database.